Kinetically controlled drug resistance: how Penicillium brevicompactum survives mycophenolic acid
- PMID: 21979957
- PMCID: PMC3220510
- DOI: 10.1074/jbc.M111.305235
Kinetically controlled drug resistance: how Penicillium brevicompactum survives mycophenolic acid
Abstract
The filamentous fungus Penicillium brevicompactum produces the immunosuppressive drug mycophenolic acid (MPA), which is a potent inhibitor of eukaryotic IMP dehydrogenases (IMPDHs). IMPDH catalyzes the conversion of IMP to XMP via a covalent enzyme intermediate, E-XMP*; MPA inhibits by trapping E-XMP*. P. brevicompactum (Pb) contains two MPA-resistant IMPDHs, PbIMPDH-A and PbIMPDH-B, which are 17- and 10(3)-fold more resistant to MPA than typically observed. Surprisingly, the active sites of these resistant enzymes are essentially identical to those of MPA-sensitive enzymes, so the mechanistic basis of resistance is not apparent. Here, we show that, unlike MPA-sensitive IMPDHs, formation of E-XMP* is rate-limiting for both PbIMPDH-A and PbIMPDH-B. Therefore, MPA resistance derives from the failure to accumulate the drug-sensitive intermediate.
Figures


Similar articles
-
A structural determinant of mycophenolic acid resistance in eukaryotic inosine 5'-monophosphate dehydrogenases.Protein Sci. 2020 Mar;29(3):686-694. doi: 10.1002/pro.3766. Epub 2019 Nov 20. Protein Sci. 2020. PMID: 31675145 Free PMC article.
-
Species-specific inhibition of inosine 5'-monophosphate dehydrogenase by mycophenolic acid.Biochemistry. 1999 Nov 16;38(46):15388-97. doi: 10.1021/bi991558q. Biochemistry. 1999. PMID: 10563825
-
Adaptive evolution of drug targets in producer and non-producer organisms.Biochem J. 2012 Jan 1;441(1):219-26. doi: 10.1042/BJ20111278. Biochem J. 2012. PMID: 21916847 Free PMC article.
-
The structure of inosine 5'-monophosphate dehydrogenase and the design of novel inhibitors.Immunopharmacology. 2000 May;47(2-3):163-84. doi: 10.1016/s0162-3109(00)00193-4. Immunopharmacology. 2000. PMID: 10878288 Review.
-
IMP dehydrogenase: mechanism of action and inhibition.Curr Med Chem. 1999 Jul;6(7):545-60. Curr Med Chem. 1999. PMID: 10390600 Review.
Cited by
-
A structural determinant of mycophenolic acid resistance in eukaryotic inosine 5'-monophosphate dehydrogenases.Protein Sci. 2020 Mar;29(3):686-694. doi: 10.1002/pro.3766. Epub 2019 Nov 20. Protein Sci. 2020. PMID: 31675145 Free PMC article.
-
De novo GTP biosynthesis is critical for virulence of the fungal pathogen Cryptococcus neoformans.PLoS Pathog. 2012;8(10):e1002957. doi: 10.1371/journal.ppat.1002957. Epub 2012 Oct 11. PLoS Pathog. 2012. PMID: 23071437 Free PMC article.
-
Resistance Gene-Directed Genome Mining of 50 Aspergillus Species.mSystems. 2019 May 14;4(4):e00085-19. doi: 10.1128/mSystems.00085-19. eCollection 2019 Jul-Aug. mSystems. 2019. PMID: 31098395 Free PMC article.
-
Evaluation of Bronopol and Disulfiram as Potential Candidatus Liberibacter asiaticus Inosine 5'-Monophosphate Dehydrogenase Inhibitors by Using Molecular Docking and Enzyme Kinetic.Molecules. 2020 May 14;25(10):2313. doi: 10.3390/molecules25102313. Molecules. 2020. PMID: 32423116 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources